{
    "clinical_study": {
        "@rank": "16773", 
        "acronym": "GAME-D2", 
        "arm_group": [
            {
                "arm_group_label": "Yogurt supplemented with vitamin D and calcium", 
                "arm_group_type": "Experimental", 
                "description": "20 participants take yogurt supplemented with vitamin D and calcium during 12 weeks"
            }, 
            {
                "arm_group_label": "Yogurt not supplemented with vitamin D and calcium", 
                "arm_group_type": "Active Comparator", 
                "description": "20 participants take yogurt not supplemented with vitamin D and calcium during 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Gait and posture disorders are very common in subjects aged 65 and over, and result mainly\n      from neuromuscular and cognitive disorders.\n\n      Many studies have shown that 1) vitamin D deficiency is very common in women aged 65 and\n      over, 2) individuals with hypovitaminosis D have lower muscle, gait and executive\n      performances and are more prone to fail than individuals with no hypovitaminosis D, 3) the\n      intake of vitamin D combined or not with calcium may improve muscle strength and cognitive\n      performance.\n\n      The investigators hypothesized that the daily intake of 2 yogurts containing 200 IU of\n      vitamin D and 400 mg of calcium 1) can improve spatiotemporal gait parameters, posture and\n      executive performance, 2) and that this improvement depends of the initial level of vitamin\n      D deficiency."
        }, 
        "brief_title": "GAit, MEmory, Dietary and Vitamin D", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Memory Complaint Without Cognitive Decline", 
        "condition_browse": {
            "mesh_term": "Cognition Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Woman aged 65 and over\n\n          -  To have hypovitaminosis D (i.e. serum 25-hydroxyvitamin D [25OHD]  concentration    \u2264\n             30ng/mL)\n\n          -  To have no hypercalcemia (defined as serum calcium concentration \u2265 2,65mmol/L)\n\n          -  Ability to walk a distance of 15 meters unaided\n\n          -  Ability to eat 2 yogurts per day\n\n          -  Memory complaint without cognitive decline\n\n          -  To have given and signed an informed consent to participate in the trial\n\n          -  To be affiliated to French Social Security\n\n          -  To have no vitamin D supplementation during inclusion\n\n        Exclusion Criteria:\n\n          -  Existence of dementia according to DSM-IV and NINCDS-ADRDA criteria and others\n             cognitive disorders: untreated thyroid dysfunction, chronic ongoing ethylism, history\n             of syphilis, stroke with sequelae, depressive symptomatology (Geriatric Depression\n             Scale > 5/15)\n\n          -  Osteoarticular diseases of the lower members and / or spine altering the\n             biomechanical characteristics of the body.\n\n          -  Vitamin D supplementation during inclusion\n\n          -  Contraindications to vitamin D\n\n          -  Unstable medical condition\n\n          -  Dairy allergy\n\n          -  Taste of dairy products not supported\n\n          -  Enrolment in another simultaneous clinical trial\n\n          -  Civil defense measures underway\n\n          -  Refusal to participate of the subject"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02086409", 
            "org_study_id": "2013-A01499-36"
        }, 
        "intervention": [
            {
                "arm_group_label": "Yogurt supplemented with vitamin D and calcium", 
                "description": "The product is a yogurt containing 200 IU of vitamin D and 400 mg of calcium. Participants take 2 yogurts per day.", 
                "intervention_name": "Yogurt supplemented with vitamin D and calcium", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Yogurt not supplemented with vitamin D and calcium", 
                "description": "The comparator is represented by a yogurt not supplemented with vitamin D and calcium.Participants take 2 yogurts per day.", 
                "intervention_name": "Yogurt not supplemented with vitamin D and calcium", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcium, Dietary", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "olbeauchet@chu-angers.fr", 
                "last_name": "Olivier Beauchet, PhD", 
                "phone": "++33241355738"
            }, 
            "facility": {
                "address": {
                    "city": "Angers", 
                    "country": "France", 
                    "state": "Maine et Loire", 
                    "zip": "49933"
                }, 
                "name": "Centre Hospitalier Universitaire d'Angers"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Dairy Product, Calcium & Vitamin D Supplementation and Congnitive-motor Function", 
        "overall_contact": {
            "email": "olbeauchet@chu-angers.fr", 
            "last_name": "Olivier Beauchet, PhD", 
            "phone": "++33241355738"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France : ANSM - French Health Products Safety Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Stride time variability is measured with spatiotemporal analysis of walking", 
            "measure": "Change in spatiotemporal gait, and in particular in the variability of stride time", 
            "safety_issue": "No", 
            "time_frame": "This outcome is assessed at baseline and 12 weeks after oral intake."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02086409"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Posture is evaluated with Time Up & Go, Five Time Sit-to-Stand and posture analysis with a platform.", 
                "measure": "Change in posture", 
                "safety_issue": "No", 
                "time_frame": "This outcome is assessed at baseline and 12 weeks after oral intake."
            }, 
            {
                "description": "Grip strength is measured with a dynamometer.", 
                "measure": "Change in grip strength", 
                "safety_issue": "No", 
                "time_frame": "This outcome is assessed at baseline and 12 weeks after oral intake."
            }, 
            {
                "description": "Executive performance is measured with Trial Making Test part B (TMT B)", 
                "measure": "Change in executive performance", 
                "safety_issue": "No", 
                "time_frame": "This outcome is assessed at baseline and 12 weeks after oral intake."
            }, 
            {
                "description": "Executive scores are assessed with digit span test (forward and backward), Trial Making Test part A (TMT A), Stoop test and Processing Speed Index", 
                "measure": "Change in other cognitive scores", 
                "safety_issue": "No", 
                "time_frame": "These outcomes are assessed at baseline and 12 weeks after oral intake."
            }, 
            {
                "description": "This outcome is assessed with the serum concentrations of 25OHD", 
                "measure": "Change in the serum concentration of  25 OHD", 
                "safety_issue": "No", 
                "time_frame": "This outcome is assessed at baseline and 12 weeks after oral intake."
            }, 
            {
                "description": "Compliance is measured by the number of yogurt capsules returned", 
                "measure": "Compliance to intervention", 
                "safety_issue": "No", 
                "time_frame": "This outcome is assessed 12 weeks after oral intake."
            }
        ], 
        "source": "University Hospital, Angers", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Angers", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}